이스라엘 -
히브리어 -
Ministry of Health
טרזוסין טבע 5 מג
teva israel ltd - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 5 mg - terazosin
이스라엘 -
히브리어 -
Ministry of Health
סינאקלסט תרו 30 מג
taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 30 mg - cinacalcet
이스라엘 -
히브리어 -
Ministry of Health
סינאקלסט תרו 30 מג
taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 30 mg - cinacalcet
이스라엘 -
히브리어 -
Ministry of Health
סינאקלסט תרו 60 מג
taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 60 mg - cinacalcet
이스라엘 -
히브리어 -
Ministry of Health
סינאקלסט תרו 60 מג
taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 60 mg - cinacalcet
이스라엘 -
히브리어 -
Ministry of Health
סינאקלסט תרו 90 מג
taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 90 mg - cinacalcet
이스라엘 -
히브리어 -
Ministry of Health
סינאקלסט תרו 90 מג
taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 90 mg - cinacalcet
이스라엘 -
히브리어 -
Ministry of Health
סובוקסון 2 מג 0.5 מג
naomi shaco-ezra ltd - buprenorphine hydrochloride; naloxone hydrochloride dihydrate - טבליות למתן מתחת ללשון - buprenorphine hydrochloride 2.16 mg; naloxone hydrochloride dihydrate 0.61 mg - buprenorphine - buprenorphine - substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. the intention of the naloxone component is to deter intravenous misuse.treatment is intended for use in adults and adolescents over 15 years of age who have agreed to be treated for addiction.
이스라엘 -
히브리어 -
Ministry of Health
סובוקסון 8 מג 2 מג
naomi shaco-ezra ltd - buprenorphine hydrochloride; naloxone hydrochloride dihydrate - טבליות למתן מתחת ללשון - buprenorphine hydrochloride 8.64 mg; naloxone hydrochloride dihydrate 2.44 mg - buprenorphine - buprenorphine - substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. the intention of the naloxone component is to deter intravenous misuse.treatment is intended for use in adults and adolescents over 15 years of age who have agreed to be treated for addiction
이스라엘 -
히브리어 -
Ministry of Health
קומפטקט 15 מג 850 מג
abic marketing ltd, israel - metformin hydrochloride; pioglitazone as hydrochloride - טבליות מצופות פילם - metformin hydrochloride 850 mg; pioglitazone as hydrochloride 15 mg - metformin